As of 2025-10-18, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -13.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 20.26 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.45 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 20.4x | 16.6x |
| Forward P/E multiples | 10.8x - 16.7x | 13.2x |
| Fair Price | (11.80) - (14.87) | (13.90) |
| Upside | -706.6% - -864.5% | -814.8% |
| Date | EV/EBITDA |
| 2025-10-16 | -14.01 |
| 2025-10-15 | -14.03 |
| 2025-10-14 | -13.99 |
| 2025-10-13 | -13.92 |
| 2025-10-10 | -14.28 |
| 2025-10-09 | -13.78 |
| 2025-10-08 | -13.85 |
| 2025-10-07 | -13.69 |
| 2025-10-06 | -14.03 |
| 2025-10-03 | -14.01 |
| 2025-10-02 | -13.78 |
| 2025-10-01 | -14.05 |
| 2025-09-30 | -14.06 |
| 2025-09-29 | -13.86 |
| 2025-09-26 | -13.77 |
| 2025-09-25 | -13.66 |
| 2025-09-24 | -16.24 |
| 2025-09-23 | -16.26 |
| 2025-09-22 | -15.80 |
| 2025-09-19 | -16.12 |
| 2025-09-18 | -15.93 |
| 2025-09-17 | -16.79 |
| 2025-09-16 | -16.81 |
| 2025-09-15 | -16.64 |
| 2025-09-12 | -16.88 |
| 2025-09-11 | -16.50 |
| 2025-09-10 | -16.51 |
| 2025-09-09 | -16.64 |
| 2025-09-08 | -16.55 |
| 2025-09-05 | -16.90 |
| 2025-09-04 | -16.79 |
| 2025-09-03 | -16.81 |
| 2025-09-02 | -16.83 |
| 2025-09-01 | -17.08 |
| 2025-08-29 | -16.51 |
| 2025-08-28 | -15.66 |
| 2025-08-27 | -16.13 |
| 2025-08-26 | -15.97 |
| 2025-08-22 | -16.22 |
| 2025-08-21 | -16.12 |
| 2025-08-20 | -15.95 |
| 2025-08-19 | -15.88 |
| 2025-08-18 | -15.99 |
| 2025-08-15 | -16.02 |
| 2025-08-14 | -15.93 |
| 2025-08-13 | -15.95 |
| 2025-08-12 | -15.95 |
| 2025-08-11 | -15.97 |
| 2025-08-08 | -15.90 |
| 2025-08-07 | -16.01 |